KBC Group NV Increases Stake in Avanos Medical, Inc. (NYSE:AVNS)

KBC Group NV lifted its holdings in shares of Avanos Medical, Inc. (NYSE:AVNSFree Report) by 63.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,833 shares of the company’s stock after purchasing an additional 1,095 shares during the period. KBC Group NV’s holdings in Avanos Medical were worth $68,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the business. Canada Pension Plan Investment Board purchased a new stake in shares of Avanos Medical during the second quarter valued at approximately $70,000. XTX Topco Ltd bought a new stake in Avanos Medical during the 2nd quarter valued at $202,000. Magnetar Financial LLC purchased a new stake in Avanos Medical during the 2nd quarter valued at $248,000. Caxton Associates LP grew its holdings in Avanos Medical by 13.6% in the 2nd quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock worth $339,000 after acquiring an additional 2,034 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of Avanos Medical by 3.6% in the second quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock valued at $341,000 after acquiring an additional 590 shares during the period. 95.17% of the stock is owned by institutional investors.

Avanos Medical Price Performance

Shares of AVNS stock opened at $18.60 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical, Inc. has a fifty-two week low of $17.39 and a fifty-two week high of $25.36. The firm has a market cap of $854.86 million, a P/E ratio of 54.71 and a beta of 0.92. The business’s 50 day moving average price is $21.73 and its 200-day moving average price is $21.53.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

View Our Latest Analysis on AVNS

Avanos Medical Company Profile

(Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Recommended Stories

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNSFree Report).

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.